BBNX - Beta Bionics, Inc.
12.2
-0.070 -0.574%
Share volume: 2,313,343
Last Updated: 04-22-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$12.27
-0.07
-0.01%
Fundamental analysis
35%
Profitability
35%
Dept financing
22%
Liquidity
73%
Performance
30%
Performance
5 Days
-5.50%
1 Month
10.71%
3 Months
-23.56%
6 Months
-39.05%
1 Year
16.63%
2 Year
-48.37%
Key data
Stock price
$12.20
DAY RANGE
$10.89 - $12.99
52 WEEK RANGE
$8.80 - $32.71
52 WEEK CHANGE
$10.31
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
Company detail
CEO: Sean Saint
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Our principal executive offices are located at 11 Hughes, Irvine, California.
Recent news